Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Pruritus Ani (Disease Or Phenotype)

Msh:D011538

Medcin:MEDCIN:111815

Mdr:MDR:10034453

Id:c27ee4f4-60db-5f35-979c-b3d9e28843ad

Icpc2icd10eng:MTHU040578

Icd10cm:L29.0

Chv:CHV:10274

Results found

Linked to

	Label	Description
	Hydrocortisone indication Pruritus Ani Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Flurandrenolide indication Pruritus Ani Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Desonide indication Pruritus Ani Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Diflorasone indication Pruritus Ani Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone Acetonide indication Pruritus Ani Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Ammonium lactate indication Pruritus Ani Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Phenylephrine indication Pruritus Ani Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	lidocaine indication Pruritus Ani Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Pruritus Ani Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Betamethasone dipropionate indication Pruritus Ani Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Hydrocortisone indication Pruritus Ani

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Flurandrenolide indication Pruritus Ani

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Desonide indication Pruritus Ani

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Diflorasone indication Pruritus Ani

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone Acetonide indication Pruritus Ani

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Ammonium lactate indication Pruritus Ani

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Phenylephrine indication Pruritus Ani

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

lidocaine indication Pruritus Ani

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Pruritus Ani

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Betamethasone dipropionate indication Pruritus Ani

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.